MAP – The game changer microneedle technology
Microneedle Patch technology is a delivery system, that shall enable active substances to overcome the skin barrier. It helps to enhance the delivery of a drug through the transdermal/intradermal route overcoming various problems associated with conventional formulations. Our Micro Array Patch (MAP) platform is based on dissolvable needles containing the API, which enables optimal load without relying on liquid reservoirs and offers many advantages for a custom-made design.
Key benefits for pharmaceutical partners
Configured specifically for the API and release option, each MAP can feature up to 1,000 needles per cm², with needle lengths ranging from 200 up to 1000μm. Microneedle technology is considered as an advantageous delivery route for existing vaccines, including e.g. influenza, tetanus toxoid, measles-rubella, Hepatitis B, as well as for biologics and small molecules.